Dr. Hino is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8230 Walnut Hill Ln
Suite 500
Dallas, TX 75231Phone+1 214-739-5821
Summary
- I am a board certified Dermatologist with interests in medical and cosmetic dermatology. Our practice delivers compassionate care in a warm environment with state of the art equipment. I have been in practice for close to 30 years and treat my patients like family, with concern and caring.
Education & Training
- University of Oklahoma Health Sciences CenterResidency, Dermatology, 1986 - 1989
- Texas Tech University Health Sciences Center at LubbockInternship, Internal Medicine, 1985 - 1986
- University of New Mexico School of MedicineClass of 1985
Certifications & Licensure
- TX State Medical License 1989 - 2025
- NM State Medical License 1994 - 2016
- OK State Medical License 1986 - 1990
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- D Magazine Top Docs
- Super Doctor SuperDoctors.com
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- A Double Blind, Placebo-Controlled, Randomized Study in Subjects With Acne Vulgaris Start of enrollment: 2015 Aug 05
Publications & Presentations
PubMed
- 89 citationsProtective effects of a topical antioxidant mixture containing vitamin C, ferulic acid, and phloretin against ultraviolet-induced photodamage in human skinChristian Oresajo, Thomas J. Stephens, Peter D Hino, Robert M Law, Margarita Yatskayer
Journal of Cosmetic Dermatology. 2008-12-01 - 5 citationsA Randomized, Double-blind, Placebo-controlled Clinical Trial Evaluating an Oral Anti-aging Skin Care Supplement for Treating Photodamaged Skin.Thomas J. Stephens, Monya L Sigler, Peter D Hino, Anne Le Moigne, Lisa Dispensa
The Journal of Clinical and Aesthetic Dermatology. 2016-04-01 - 51 citationsRandomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1-, 2-, or 4-week treatment in patients with actinic keratosis.Joseph L. Jorizzo, Daniel Stewart, Alicia D. Bucko, Steven A Davis, Paul Espy
Cutis. 2002-12-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: